Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Secreted frizzled related protein (sFRP)-2 inhibits bone formation and promotes cell proliferation in ameloblastoma
Oral Oncology , 09/08/09
Sathi GA et al. – It was confirmed that ameloblastoma cells have a major role in decreased bone formation by secreting sFRP–2 in cell culture model. Though, sFRP–2 has great effect on tumor progression, inhibition of sFRP–2’s anti–bone formation activity and cell proliferative activity may reduce the invasive property of ameloblastoma and possibility of recurrence rate.
Related Articles
Immortalization of ameloblastoma cells via reactivation of telomerase function: Phenotypic and molecular characteristics
Oral Oncology, 10/23/09
Relevance Score: 83%
The diagnosis and treatment of dentinogenic ghost cell tumor
International Journal of Oral and Maxillofacial Surgery, 10/27/09
Relevance Score: 80%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer
Cancer Treatment Reviews, 12/04/09
Dysregulation of Platelet-Derived Growth Factor beta-Receptor Expression by deltaNp73 in Neuroblastoma
Molecular Cancer Research, 12/04/09
Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression
Virchows Archiv, 12/04/09
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma
BMC Cancer, 12/04/09
Predictors of Competing Mortality in Advanced Head and Neck Cancer
Journal of Clinical Oncology, 12/04/09
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma
Journal of Cancer Research & Clinical Oncology, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


